CFDE Data Portal | Search PGLYRP1

	Label	Description
	PGLYRP1 Gene (Entity type)	ENSG00000008438 - peptidoglycan recognition protein 1
	PGLYRP1 associations Collection (Entity type)	Associations for PGLYRP1_associations
	PGLYRP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE101239 5 V 6 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE110178 5 V 0 TRANYLCYPROMINE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE166536 3 V 2 DOCETAXEL MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 0 V 12 LENALIDOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE147834 1 V 0 DOXORUBICIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

PGLYRP1

ENSG00000008438 - peptidoglycan recognition protein 1

PGLYRP1 associations

Associations for PGLYRP1_associations

PGLYRP1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN

A Gene Set from LINCS

GSE101239 5 V 6 VALPROIC ACID MOUSE UP

A Gene Set from LINCS

GSE110178 5 V 0 TRANYLCYPROMINE MOUSE UP

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 8 v 5 human dn

A Gene Set from LINCS

GSE166536 3 V 2 DOCETAXEL MOUSE UP

A Gene Set from LINCS

GSE76425 0 V 12 LENALIDOMIDE HUMAN DN

A Gene Set from LINCS

GSE147834 1 V 0 DOXORUBICIN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.